drugset / Trial / NCT07152444
A Phase I Trial of QLS1410 in Healthy Chinese Adults and Participants With Mild Essential Hypertension
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The goal of this clinical trial is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and food effect of single and multiple ascending doses of QLS1410 in healthy Chinese adults and participants with mild essential hypertension
Timeline
- Start
- 2025-09
- Primary completion
- 2026-05
- Completion
- 2026-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | QLS1410 | Unknown | 0.5 mg | Oral |
| Subject | QLS1410 | Unknown | 1.5 mg | Oral |
| Subject | QLS1410 | Unknown | 20 mg | Oral |